BRNS (Barinthus Biotherapeutics) Forvard P/E multiplikatori

Barinthus Bio (BRNS) kompaniyasining korporativ logotipi

Barinthus Biotherapeutics AQSH va Buyuk Britaniyadagi virologlar va immunologlardan iborat kuchli xodimlar jamoasiga tayanadi. Biznesning forward P/E koeffitsiyenti joriy xavfsizlik zaxirasini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning joriy qiymatini aks ettiradi. O'sish potentsiali vaksinalar tasdiqlanishi bo'yicha texnologik gigantlar bilan bo'lgan shiddatli raqobat tufayli cheklangan; biroq, "yashil kimyo"ni joriy etish va bioetikaga rioya qilish kompaniyaning investitsiyaviy jozibadorligini kuchaytiradi.

Prognoz qilingan narxning foydaga nisbati: Barinthus Biotherapeutics plc (BRNS) 21.02.2024 - 19.09.2026 uchun

Barinthus Biotherapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:barinthusbio.com
Barinthus Biotherapeutics tovar namunasi

Barinthus Biotherapeutics (BRNS) kompaniyasida virusli kasalliklar uchun immunoterapiyaning ishlab chiqilishi va ilmiy loyihalar portfelining kengayishi kompaniyaning forward P/E koeffitsiyentini hisoblashda foydalaniladigan kutilayotgan sof foydaga bevosita ta'sir qiladi. Joriy aksiya narxini 10-Q va 10-K hisobotlariga asoslangan prognoz qilingan daromadlar bilan solishtirish investorlarga kelajakdagi o'sish uchun to'langan premiumni baholash va aktivning bozor zarbalariga chidamliligini aniqlash imkonini beradi.

Barinthus Biotherapeutics (BRNS) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|KZR (Kezar Life Sciences, Inc.) - Forvard P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori AKTX|Kelajakdagi narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Kelajakdagi narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Prognoz qilingan narxning foydaga nisbati|EDSA - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iBio|CARM: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Kelajakdagi narxning foydaga nisbati boltbio.com|Forvard P/E multiplikatori HCW Biologics|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori